Europe leads the world in discovery — yet too often, its breakthroughs never become global companies. Billions in research funding turn into patents, not products. While others build empires from ideas, Europe risks becoming the world’s laboratory — brilliant, but broke. That’s the paradox at the heart of this conversation. In this episode, Karl Nehammer, Vice-President of the European Investment Bank (EIB) and former Chancellor of Austria, joins Christian Soschner live at BIO-Europe 2025 to ...
All content for Beginner's Mind is the property of Christian Soschner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Europe leads the world in discovery — yet too often, its breakthroughs never become global companies. Billions in research funding turn into patents, not products. While others build empires from ideas, Europe risks becoming the world’s laboratory — brilliant, but broke. That’s the paradox at the heart of this conversation. In this episode, Karl Nehammer, Vice-President of the European Investment Bank (EIB) and former Chancellor of Austria, joins Christian Soschner live at BIO-Europe 2025 to ...
EP 153 - Christopher Uhde: The Biotech IPO Boom is Over. Now What?
Beginner's Mind
2 hours 2 minutes
8 months ago
EP 153 - Christopher Uhde: The Biotech IPO Boom is Over. Now What?
In 2021, biotech IPOs were soaring. Valuations hit record highs. Investors were throwing money at anything that moved. Then… the market crashed. Funding dried up. Growth stalled. Biotech founders and investors were left scrambling. So what really happened? And more importantly—how do you navigate what’s next? 📌 In this episode, Christopher Uhde—Senior Pharma & Biotech Equity Analyst at SEB—breaks down the brutal realities of biotech IPOs, investor sentiment, and the high-stakes game of su...
Beginner's Mind
Europe leads the world in discovery — yet too often, its breakthroughs never become global companies. Billions in research funding turn into patents, not products. While others build empires from ideas, Europe risks becoming the world’s laboratory — brilliant, but broke. That’s the paradox at the heart of this conversation. In this episode, Karl Nehammer, Vice-President of the European Investment Bank (EIB) and former Chancellor of Austria, joins Christian Soschner live at BIO-Europe 2025 to ...
